Detalhe da pesquisa
1.
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol.
Blood
; 141(5): 529-533, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240445
2.
Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis.
Haematologica
; 96(12): 1815-21, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21880630
3.
Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment.
Leuk Lymphoma
; 62(3): 752-754, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33118409